ADDRESSING THE RISKS IN THE VEIN TO VEIN CELL THERAPY SUPPLY CHAIN

Lonza enters a partnership with Vineti to advance its ‘vein-to-vein’ delivery network, creating an end-to-end ordering and manufacturing process in support of cell and gene therapy development.

Read the full story on Outsourcing-Pharma, click here